Aspen Aerogels, Inc.

Aspen Aerogels, Inc. Q2 2025 Earnings Recap

ASPN Q2 2025 August 8, 2025

Get alerts when ASPN reports next quarter

Set up alerts — free

Aspen Aerogels reported Q2 2025 revenues of $78 million, marking a 34% year-over-year decline, though results came in at the higher end of expectations, reflecting ongoing operational improvements and a commitment to profitability.

Earnings Per Share Beat
$-0.04 vs $-0.12 est.
+66.7% surprise
Revenue Beat
78024000 vs 70483710 est.
+10.7% surprise

Market Reaction

1-Day -5.49%
5-Day -8.43%
30-Day -9.5%

See ASPN alongside your other holdings

Add to your portfolio — free

Key Takeaways

  • Adjusted EBITDA expected to double in the second half of 2025 due to cost optimization efforts and streamlined operations.
  • Significant cost reductions of approximately $65 million achieved, aligning operational expenses with 2022 levels.
  • Energy & Industrial segment revenue declined 38% year-over-year, primarily impacted by a slowdown in Subsea project activities.
  • Plans for new CFO Grant Thoele to enhance financial strategy and transition smoothly from departing CFO Ricardo Rodriguez by Q3.
  • Strong outlook for 2026 with anticipated recovery in subsea and LNG project revenues driven by favorable market conditions.
This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit ASPN on AllInvestView.

Get the Full Picture on ASPN

Track Aspen Aerogels, Inc. in your portfolio with real-time analytics, dividend tracking, and more.

View ASPN Analysis